Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ACAD Stock Annual Cash Flow. Download in Excel

ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

16.87
 
USD
  
0.14
  
(0.84%)
Previous close: 16.73  Open: 16.51  Bid: 16.51  Ask: 16.83
52 week range    
14.15   
   31.93
Mkt Cap: 2,897 M  Avg Vol (90 Days): 1,477,286
Peers   
VNDA / 
BMY / 
PFE / 
JNJ / 
Last updated: Monday 23rd December 2024

Stock Rankings

55
MarketXLS Rank
55
Value
61
Technical
50
Quality
How are these ranks calculated?
Search for a stock

Financials

ACAD Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories-3 M-1 M2 M-2 M-3 M-4 M2 M-29 M
(Increase) Decrease in other current assets-108000.0-417000.0-2 M431000.0-236000.039000.0182000.0
(Increase) Decrease in other current liabilities72000.097000.03 M-3 M1 M1 M2 M2 M2 M6 M
(Increase) Decrease in other working capital39000.0182000.010000.0-48000.0-33000.0
(Increase) Decrease in payables2 M-344000.02 M5 M-6 M4 M1 M-2 M6 M5 M
(Increase) Decrease in receivables-214000.0-674000.0-6 M-11 M-9 M-10 M-12 M-15 M2 M-39 M
Amortization of intangibles985000.01 M2 M2 M2 M1 M4 M
CapitalExpenditureReported180000.02 M10 M812000.02 M1 M8 M1 M40 M
Cash at beginning of period12 M62 M102 M166 M72 M140 M194 M332 M153 M121 M
Cash at end of period62 M102 M164 M72 M140 M195 M332 M153 M121 M194 M
Cash flow-66 M-122 M-210 M-218 M-167 M-151 M-136 M-126 M-114 M17 M
CashFlowFromContinuingInvestingActivities-87 M148 M-262 M92 M-71 M-166 M193 M-71 M73 M32 M
ChangeInAccountPayable2 M-344000.02 M5 M-6 M4 M1 M-2 M6 M5 M
ChangeInAccruedExpense7 M6 M16 M4 M16 M6 M28 M-8 M24 M93 M
ChangeInInterestPayable7 M6 M16 M4 M16 M6 M28 M
ChangeInPayablesAndAccruedExpense9 M6 M18 M9 M10 M11 M29 M-10 M30 M98 M
ChangeInPrepaidAssets652000.0-804000.0-5 M-911000.0-12 M2 M-7 M2 M2 M-18 M
ChangeInWorkingCapital9 M4 M4 M-6 M-8 M2 M9 M-26 M39 M18 M
ChangesInAccountReceivables-214000.0-674000.0-6 M-11 M-9 M-10 M-12 M-15 M2 M-39 M
Depreciation206000.0647000.0843000.01 M2 M1 M2 M2 M2 M2 M
Depreciation unreconciled690000.0-1 M2 M2 M2 M-813000.04 M6 M-736000.0-2 M
DepreciationAndAmortization690000.0-1 M2 M2 M2 M-813000.03 M3 M2 M6 M
Effect of exchange rate changes3000.07000.02000.0-6000.03000.02000.0-8000.07000.06000.0-18000.0
ExcessTaxBenefitFromStockBasedCompensation-247000.0-596000.0
FinancingCashFlow204 M15 M534 M31 M307 M372 M81 M18 M8 M25 M
Free cash flow-67 M-124 M-220 M-219 M-170 M-152 M-144 M-127 M-114 M-23 M
GainLossOnInvestmentSecurities-997000.0997000.0-2 M-4 M-5 M
GainLossOnSaleOfPPE5000.04000.088000.03000.0281000.0
IncomeTaxPaidSupplementalData415000.0365000.01 M1 M2 M1 M1 M2 M6 M
Issuance of capital stock204 M15 M519 M31 M307 M372 M81 M18 M8 M25 M
IssuanceOfCapitalStock204 M15 M519 M31 M307 M372 M81 M18 M8 M25 M
Net cash from financing activities204 M15 M534 M31 M307 M372 M81 M18 M8 M25 M
Net cash from investing activities-87 M148 M-262 M92 M-71 M-166 M193 M-71 M73 M32 M
Net cash from operating activities-66 M-122 M-210 M-218 M-167 M-151 M-136 M-126 M-114 M17 M
Net change in cash & cash equivalents50 M40 M61 M-94 M68 M55 M137 M-179 M-33 M74 M
Net income from continuing operations-92 M-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M-61 M
NetCommonStockIssuance204 M15 M519 M31 M307 M372 M81 M18 M8 M25 M
NetIntangiblesPurchaseAndSale-8 M-40 M
NetInvestmentPropertiesPurchaseAndSale-87 M150 M-252 M93 M-69 M-165 M200 M-70 M73 M72 M
NetInvestmentPurchaseAndSale-87 M150 M-252 M93 M-69 M-165 M200 M-70 M73 M72 M
NetPPEPurchaseAndSale-180000.0-2 M-2 M-812000.0-2 M-1 M-8 M-1 M-50000.0
Operating (gains) losses5000.04000.02 M-994000.01 M-2 M-4 M-5 M
Other financing charges net-45000.015 M
Other investing changes net-8 M12 M
Other non-cash items16 M40 M55 M76 M82 M84 M131 M64 M67 M66 M
Purchase of Float term investments-335 M-269 M-683 M-479 M-331 M-579 M-340 M-493 M-363 M-370 M
Purchase of property plant & equipment-180000.0-2 M-10 M-812000.0-2 M-1 M-8 M-1 M-40 M
PurchaseOfIntangibles-8 M-40 M
PurchaseOfInvestment-335 M-269 M-683 M-479 M-331 M-579 M-340 M-493 M-363 M-370 M
PurchaseOfPPE-180000.0-2 M-2 M-812000.0-2 M-1 M-8 M-1 M-50000.0
Revenue per share484000.0-2 M1 M1 M922000.0-2 M3 M4 M-3 M-3 M
Sale of short term investments248 M419 M431 M572 M262 M414 M540 M423 M436 M430 M
SaleOfInvestment248 M419 M431 M572 M262 M414 M540 M423 M436 M430 M
SaleOfPPE44000.0
StockBasedCompensation16 M40 M55 M76 M82 M82 M84 M64 M68 M66 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University